期刊文献+

心脏嗜铬细胞瘤的影像学诊断 被引量:7

Imaging features of cardiac pheochromocytomas
原文传递
导出
摘要 目的描述心脏嗜铬细胞瘤的影像学表现,探讨其诊断意义。方法回顾性分析4例经手术病理证实的心脏嗜铬细胞瘤,着重分析其影像学表现和意义。结果4例心脏嗜铬细胞瘤平均直径5·8cm,分别位于左房顶部、房间隔、升主动脉基部前方、主动脉弓和肺动脉之间。1例患者合并双侧颈动脉体瘤。肾上腺髓质显像1例阳性。生长抑素受体显像4例阳性。肿瘤CT平扫与心脏等密度,增强时有明显增强,均可见低增强的中心瘢痕。MRI显示与心肌相比为略短或等T1信号、长T2信号。冠状动脉造影4例显示肿物血供。结论心脏嗜铬细胞瘤主要位于左心房顶部及附近。肾上腺髓质显像和生长抑素受体显像结合可有效探查肿物位置和数目。增强CT和MR平扫可显示肿物细节,有助于手术评估。 Objective To describe imaging features of cardiac pheochromocytomas and discuss the value on diagnosis. Methods Imaging features of 4 pathologically confirmed cardiac pheochromocytomas were retrospectively studied. Results The mean diameter of the 4 tumors was 5.8 cm, and the tumors were located respectively in the roof of left atrium, in the interatrial septum in front of the base of ascending aorta, and in between the aortic arch and the pulmonary trunk. Bilateral carotid body tumors were also seen in 1 case. MIBG scintigraphy was positive in 1 case. Somatostatin receptor scintigraphy showed all tumors. The tumors were of same CT attenuation as the heart and were enhanced significantly on enhanced CT. All the tumors had central scar on enhanced CT. The tumors were of shorter or iso-signal intensity on T1WI, and of long signal intensity on T2WI. Coronary angiography depicted feeding arteries of all 4 tumors. Conclusion Cardiac pheochromocytomas are rare tumors, typically located adjacent to or involving the left atrium. For initial detection of multiple foci, MIBG scintigraphy combined with somatostatin receptor scintigraphy is recommended. MRI and enhanced CT imaging can then provide detailed anatomic delineation before surgical resection.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2005年第7期696-699,共4页 Chinese Journal of Radiology
  • 相关文献

参考文献12

  • 1Hamilton BH, Francis IR, Gross BH, et al. Intrapericardial paragangliomas(pheochromocytomas): imaging features. AJR,1997,168: 109-113.
  • 2Aravot DJ, Banner NR, Cantor AM, et al. Location, localization and surgical treatment of cardiac pheochromocytoma(Review). Am J Cardiol ,1992,69: 283-285.
  • 3Jebara VA, Uva MS, Farge A, et al. Cardiac pheochromocytomas(Review). Ann Thorac Surg ,1992,53:356-361.
  • 4Meunier JP, Tatou E, Bernard A, et al. Cardiac pheochromocytoma. Ann Thorac Surg, 2001,71: 712-713.
  • 5Orringer MB, Sisson JC, Glazer G, et al. Surgical treatment of cardiac pheochromocytomas. J Thorac Cardiovasc Surg ,1985, 89: 753-757.
  • 6Grebenc ML, Rosado de Christenson ML, Burke AP, et al. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation(Review). Radiographics,2000,20:1073-1103.
  • 7Araoz PA, Mulvagh SL, Tazelaar HD, et al. CT and MR imaging of benign primary cardiac neoplasms with echocardiographic correlation(Review). Radiographics,2000,20:1303-1319.
  • 8Kaltsas G, Korbonits M, Heintz E, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab,2001, 86:895-902.
  • 9李方,陈黎波,景红丽,杜延荣,陈方.^(99)Tc^m-HYNIC-TOC-生长抑素受体肿瘤显像的临床应用[J].中国医学科学院学报,2003,25(5):563-566. 被引量:6
  • 10Shulkin BL, Thompson NW, Shapiro B, et al. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology ,1999,212:35-41.

二级参考文献9

  • 1Kwekkeboom DJ, Krenning EP.Somatostatin receptor imaging. Semin in Nucl Med, 2002, 32(2):84-91
  • 2Bakker WH, Albert R, Bruns C, et al. 111ln-DTPA-D-Phe1octreotide, a potentialradiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis,radiolabelling and in vitro validation. Life Sci, 1991, 49(22):1583-1591
  • 3Krenning EP, Bakker WH, Breemon WAP, et al. Localisation of endocrine-relatedtumors with radioiodinated analogue of somatostatin. Lancet, 1989, 1(8632):242-244
  • 4Decristoforo C, Mather SJ, Choleewinski W, et al. 99TcmEDDA/HYNIC-TOC: a new99Tcm-labelled radiopharmaceuticl for imaging somatostatin receptor-positive tumours:first clinical results and intra-patient comparison with 111In-labelled octreotidederivatives. Eur J Nucl Med, 2000, 27(9):1318-1325
  • 5Boernan OC, Oyen WJG, Corstens FHM. Radio-labeled receptor-binding peptides: a newclass of radiopharmaceuticals. Semin in Nucl Med, 2000, 30(3):195-208
  • 6Olsen JO, Pozderac RV, Hinkle G, et al. Somatostatin receptor imaging ofneuroendocrine tumors with IndiumPentetreotide (OctreoScan). Semin in Nucl Med, 1995,25(3):251-261
  • 7Jong MD, Valkema R, Jamar F, et al. Somatostatin receptor-targeted radionuclidetherapy of tumors: preclinical and clinical findings. Semin in Nucl Med, 2002,32(2):133-140
  • 8Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scitintigraphywith (111In-DTPA-Phe) and (123I-Try3)-octreotide: the Rotterdam experience with more than1000 patients. Eur J Nucl Med, 1993, 20(8):716-731
  • 9张宝牛,李方,陈方.生长抑素受体显像在甲状腺髓样癌诊断中的应用[J].中华核医学杂志,2000,20(1):3-4. 被引量:5

共引文献5

同被引文献37

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部